Divergent functions of TLRs in gastrointestinal (GI) cancer: Overview of their diagnostic, prognostic and therapeutic value
Authors:
- 9 May 2025
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 52 (3) , 152344
Abstract
No abstract availableKeywords
Funding Information
- Shaqra University
This publication has 203 references indexed in Scilit:
- Slimming and Reinvigorating Tumor‐Associated Dendritic Cells with Hierarchical Lipid Rewiring NanoparticlesAdvanced Materials, 2023
- Antigen‐Capturing Dendritic‐Cell–Targeting Nanoparticles for Enhanced Tumor Immunotherapy Based on Photothermal‐Therapy–Induced In Situ VaccinationAdvanced Healthcare Materials, 2023
- Direct Presentation of Tumor‐Associated Antigens to Induce Adaptive Immunity by Personalized Dendritic Cell‐Mimicking NanovaccinesAdvanced Materials, 2022
- Tumor‐associated human dendritic cell subsets: Phenotype, functional orientation, and clinical relevanceEuropean Journal of Immunology, 2022
- Migration of murine intestinal dendritic cell subsets upon intrinsic and extrinsic TLR3 stimulationEuropean Journal of Immunology, 2020
- Cancer in Africa 2018: The role of infectionsInternational Journal of Cancer, 2019
- Toll‐like receptor 2 regulates metabolic reprogramming in gastric cancer via superoxide dismutase 2International Journal of Cancer, 2018
- The contribution of toll‐like receptor signaling to the development of liver fibrosis and cancer in hepatocyte‐specific TAK1‐deleted miceInternational Journal of Cancer, 2017
- Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and functionEuropean Journal of Immunology, 2017
- Toll‐like receptor genes and their association with colon and rectal cancer development and prognosisInternational Journal of Cancer, 2011